Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YM758 in stable angina (4-week randomized trial)
2005-002456-18Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in stable angina comparing YM758 with Placebo (2 arms). Primary endpoint: Safety and tolerability of YM758. Started Mar 2006; status: completed.
02
Drugs
YM758
03
Conditions
stable angina
Beyond the preview
Go deeper on 2005-002456-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002456-18.